JPS6216638B2 - - Google Patents

Info

Publication number
JPS6216638B2
JPS6216638B2 JP56189856A JP18985681A JPS6216638B2 JP S6216638 B2 JPS6216638 B2 JP S6216638B2 JP 56189856 A JP56189856 A JP 56189856A JP 18985681 A JP18985681 A JP 18985681A JP S6216638 B2 JPS6216638 B2 JP S6216638B2
Authority
JP
Japan
Prior art keywords
culture
aiu
inhibitor
inhibitors
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56189856A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57150395A (en
Inventor
Furomaa Uerunaa
Purusu Warutaa
Sheefuaa Deiitomaa
Shumitsuto Derufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS57150395A publication Critical patent/JPS57150395A/ja
Publication of JPS6216638B2 publication Critical patent/JPS6216638B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
JP56189856A 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme Granted JPS57150395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (2)

Publication Number Publication Date
JPS57150395A JPS57150395A (en) 1982-09-17
JPS6216638B2 true JPS6216638B2 (OSRAM) 1987-04-14

Family

ID=5792372

Family Applications (3)

Application Number Title Priority Date Filing Date
JP10558571A Pending JPS5734996B1 (OSRAM) 1970-12-28 1971-12-27
JP56189856A Granted JPS57150395A (en) 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme
JP56189857A Granted JPS57150396A (en) 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP10558571A Pending JPS5734996B1 (OSRAM) 1970-12-28 1971-12-27

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP56189857A Granted JPS57150396A (en) 1970-12-28 1981-11-26 Production of inhibitor for glycoside hydrolyzing enzyme

Country Status (28)

Country Link
US (1) US3876766A (OSRAM)
JP (3) JPS5734996B1 (OSRAM)
KR (1) KR780000248B1 (OSRAM)
AR (1) AR193370A1 (OSRAM)
AT (1) AT330122B (OSRAM)
AU (1) AU461521B2 (OSRAM)
BE (1) BE777387A (OSRAM)
BG (3) BG25654A3 (OSRAM)
CA (1) CA979833A (OSRAM)
CH (1) CH594051A5 (OSRAM)
CS (1) CS167961B2 (OSRAM)
DD (1) DD99395A5 (OSRAM)
DE (1) DE2064092C2 (OSRAM)
DK (1) DK139533C (OSRAM)
ES (1) ES398358A1 (OSRAM)
FI (1) FI49774C (OSRAM)
FR (1) FR2120073B1 (OSRAM)
GB (1) GB1374751A (OSRAM)
IE (1) IE35920B1 (OSRAM)
IL (1) IL38441A (OSRAM)
LU (1) LU64319A1 (OSRAM)
NL (1) NL175199C (OSRAM)
NO (1) NO135873C (OSRAM)
PL (1) PL82900B1 (OSRAM)
RO (3) RO63064A (OSRAM)
SE (1) SE398357B (OSRAM)
SU (1) SU454750A3 (OSRAM)
ZA (1) ZA718677B (OSRAM)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
ES2056801T3 (es) * 1986-08-13 1994-10-16 Hoechst Ag Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
AU7457300A (en) 1999-10-28 2001-05-08 Chong Kun Dang Pharmaceutical Corp. A process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
WO2013083566A1 (en) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh New actinomycete integrative and conjugative element from actinoplanes sp. se50/110 as plasmid for genetic transformation of related actinobacteria
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
JP7711052B2 (ja) 2019-10-16 2025-07-22 バイエル・アクチエンゲゼルシヤフト アカルボースの改善された形成方法
WO2021195087A1 (en) 2020-03-23 2021-09-30 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
FI49774B (OSRAM) 1975-06-30
US3876766A (en) 1975-04-08
IL38441A (en) 1974-10-22
DD99395A5 (OSRAM) 1973-08-05
SE398357B (sv) 1977-12-19
KR780000248B1 (en) 1978-07-06
IE35920B1 (en) 1976-06-23
NO135873C (OSRAM) 1977-06-15
IE35920L (en) 1972-06-28
DE2064092A1 (de) 1972-07-20
AR193370A1 (es) 1973-04-23
DK139533C (da) 1979-08-20
JPS57150395A (en) 1982-09-17
BG26002A4 (bg) 1979-01-12
ZA718677B (en) 1972-09-27
CA979833A (en) 1975-12-16
GB1374751A (en) 1974-11-20
DK139533B (da) 1979-03-05
RO63065A (fr) 1979-02-15
JPS5734996B1 (OSRAM) 1982-07-26
NL175199B (nl) 1984-05-01
FR2120073A1 (OSRAM) 1972-08-11
CH594051A5 (OSRAM) 1977-12-30
LU64319A1 (OSRAM) 1972-06-13
IL38441A0 (en) 1972-02-29
AU461521B2 (en) 1975-05-29
JPS6234396B2 (OSRAM) 1987-07-27
AT330122B (de) 1976-06-10
JPS57150396A (en) 1982-09-17
NL175199C (nl) 1984-10-01
RO63064A (fr) 1978-06-15
ES398358A1 (es) 1974-09-01
BE777387A (fr) 1972-06-28
AU3721471A (en) 1973-09-27
CS167961B2 (OSRAM) 1976-05-28
FI49774C (fi) 1975-10-10
DE2064092C2 (de) 1983-06-01
RO61400A (OSRAM) 1977-01-15
ATA1111571A (de) 1975-09-15
BG25654A3 (bg) 1978-11-10
NO135873B (OSRAM) 1977-03-07
BG26003A4 (bg) 1979-01-12
FR2120073B1 (OSRAM) 1975-12-26
PL82900B1 (OSRAM) 1975-10-31
SU454750A3 (ru) 1974-12-25
NL7117893A (OSRAM) 1972-06-30

Similar Documents

Publication Publication Date Title
JPS6234396B2 (OSRAM)
NO813407L (no) Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse
FR2853908A1 (fr) Produit immunomodulateur obtenu a partir d'une culture de bifidobacterium et compositions le contenant
IE63272B1 (en) The glycosidase inhibitor salbostatin, process fo r its preparation and its use
US4010258A (en) Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4019960A (en) Process for the production of a saccharase inhibitor
US4282318A (en) α-Amylase inhibitor from a streptomycete and process for its preparation
US3985869A (en) Dental caries-inducing microorganism cells lytic enzyme
KR0177832B1 (ko) 감초 추출물을 사용한 조성물
US3937817A (en) Pharmaceutical compositions containing a saccharase inhibitor
SU1732815A3 (ru) Способ получени гипотриглицеридально-активных полисахаридов
CN118598981B (zh) 经生物发酵后酶解制作鱼胶原蛋白肽的方法及产品和应用
King et al. Pantothenic acid studies. VI. A biologically active conjugate of pantothenic acid
US4271067A (en) Glycopeptide
US3855066A (en) Process for the production of an amylase inhibitor
WO1997023605A1 (en) Thermostable proteolytic enzyme from thermoactinomyces thalpophilus thm1
JPS58318B2 (ja) 制癌性物質の製造方法
JPS6178396A (ja) 新規α‐グルコシダーゼ抑制剤およびその製法
US4013510A (en) Glycoside-hydrolase enzyme inhibitors
JPS61134398A (ja) 新生理活性物質プリパスタチン及びその製造法
US3951745A (en) Glycoside-hydrolase enzyme inhibitors
US3995026A (en) Amylase inhibitor
US3879546A (en) Saccharase inhibitors
KR890002256B1 (ko) 항암 물질 tf-2 제조 방법
SU1756349A1 (ru) Штамм бактерий СоRYNевастеRIUм SереDоNIсUм - продуцент полисахарида, индуцирующего образование интерферона